Cera Sanitaryware Ltd

- There is no mention of any current or planned fundraising through debt or equity in the transcript. - The company discusses cost optimization, brand expansion (Senator and Polipluz), and operational efficiencies but does not indicate raising funds via debt or equity. - Focus is on internal growth initiatives, expanding distribution networks, and new product launches rather than external capital raising. - No discussion or guidance regarding capital raising activities during Q2 FY26 earnings call.

- For FY 2026, CERA Sanitaryware Ltd. has earmarked a capex outlay of around INR 23 crore. - The capex primarily covers routine maintenance requirements. - There are focused investments planned to strengthen brand presence. - Plans also include expanding the retail footprint. - Capital allocation remains prudent and aligned with long-term strategic priorities. - Investments are targeted to ensure clear visibility on returns and long-term value creation. - No mention of new large-scale strategic investments beyond brand and retail expansion as of Q2 FY26.

Future growth expectations for CERA Sanitaryware Ltd. as per the Q2 FY26 earnings call are: - **Full-year revenue growth guidance:** 7% to 8% growth for FY26 overall. - **H2 FY26 growth:** Anticipated 10% to 12% revenue growth, improving from 2% in H1. - **Segment-specific growth:** - Faucetware: Expected 8% to 10% revenue growth for full year FY26. - Sanitaryware showed marginal growth (approx. 1.4% in Q2). - **New brands Senator and Polipluz:** - Targeting INR 45-50 crore revenue in H2 FY26. - Forecasted combined revenue of INR 150 crore by FY27. - **Volume and price dynamics:** Volume growth remains key, but price increases are moderate and lagged due to project contracts. - **Operational efficiencies and cost optimization:** Ongoing efforts expected to support margin stability amid market demand fluctuations. Overall, the company is cautiously optimistic about demand revival in H2 FY26 and beyond.

- Full-year revenue growth guidance for FY26 is 7% to 8%, with H2 expected to deliver 10%-12% growth, improving from 2% in H1. - Operating margins are expected to be maintained in the 14.5% to 15% range for FY26, improving in H2 due to higher volumes. - Earnings per share (EPS) for Q2 FY26 was INR 43.92, compared to INR 52.44 in Q2 FY25; PAT for H1 FY26 was INR 103 crore, slightly lower than INR 115 crore in H1 FY25 due to one-time tax effects. - New brands Senator and Polipluz are expected to contribute INR 40-45 crore in sales in H2 FY26 and target INR 150 crore revenue by FY27. - Cost optimization and operational efficiencies will support margin sustainability despite inflationary pressures. - The company remains cautiously optimistic about demand recovery in H2 FY26, driven by stable interest rates, government spending, and improving consumer sentiment.

The transcript does not explicitly mention the current or expected order book or pending orders figures for CERA Sanitaryware Ltd. However, key related points include: - Project sales accounted for 39% of the topline in Q2 FY26. - The company continues to benefit from strong relationships across the developer ecosystem, enabling participation in larger and more complex projects. - Steady order inflows from the real estate sector and sustained construction activity support healthy traction in the B2B (project) segment. - The company views the project business as an important growth pillar, balancing softness in retail demand. - The contribution from the project business is expected to remain around 39%-40% for FY26. - Demand in retail is showing some green shoots with expectations of growth in H2 FY26, potentially affecting order inflows positively. No specific numerical order book or pending orders value is disclosed in the transcript.